BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price reached a new 52-week high during trading on Thursday . The company traded as high as $1.63 and last traded at $1.51, with a volume of 46107 shares trading hands. The stock had previously closed at $1.54.
BioRestorative Therapies Price Performance
The stock’s 50 day moving average price is $1.63 and its two-hundred day moving average price is $1.59. The firm has a market capitalization of $2.48 billion, a price-to-earnings ratio of -1.44 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Options Trading – Understanding Strike Price
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How to Calculate Stock Profit
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
